Redefining Success in Hypotony Treatment

Chronic ocular hypotony presents a complex challenge for ophthalmologists, often leading to irreversible damage if not addressed properly. Dr. Harry Petrushkina from Moorfields Hospital discusses innovative findings from a study on intravitreal hydroxypropylmethylcellulose (HPMC), revealing a potential method to restore vision and eye structure. By focusing on biomechanical principles and defining treatment endpoints, this approach showed significant visual improvements in patients, hinting at a new direction in managing this previously difficult condition.

About the Author(s)

Julian Upton

Julian Upton is Group Editor at Conexiant Europe. With 25 years' experience of the magazine industry, he has covered many facets of science and healthcare.

More Articles by Julian Upton